(Q38061012)

28 August 2017

1 reference

title

The retina as a window to the brain-from eye research to CNS disorders (English)

1 reference

28 August 2017

3

Michal Schwartz

1 reference

28 August 2017

1

Anat London

1 reference

28 August 2017

2

Inbal Benhar

1 reference

PubMed ID

23165340

28 August 2017

language of work or name

English

0 references

publication date

20 November 2012

1 reference

28 August 2017

Nature Reviews Neurology

1 reference

28 August 2017

9

1 reference

28 August 2017

1

1 reference

28 August 2017

44-53

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2012.227

28 August 2017

0 references

cites work

Pharmacological strategies in CNS trauma

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Rewiring the injured CNS: lessons from the optic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Nogo and axon regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Regeneration beyond the glial scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Axonal Elongation into Peripheral Nervous System "Bridges" After Central Nervous System Injury in Adult Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Ocular immune privilege: therapeutic opportunities from an experiment of nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Cerebral white matter lesions, retinopathy, and incident clinical stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal signs and stroke: revisiting the link between the eye and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Lacunar stroke is associated with diffuse blood-brain barrier dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optic neuritis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Dopaminergic modulation of visual sensitivity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

The retina in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal nerve fiber layer thinning in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Inner retinal layer thinning in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Alzheimer's disease and retinal neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optic-nerve degeneration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal ganglion cell degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Morphological and functional retinal impairment in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal abnormalities in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optic nerve damage in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Ocular manifestations of central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Axonal degeneration in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Glaucoma as a neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal tau pathology in human glaucomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Targeting amyloid-beta in glaucoma treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

The potential role of amyloid beta in the pathogenesis of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Soluble and mature amyloid fibrils in drusen deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Iron misregulation in the brain: a primary cause of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Increased expression of iron-regulating genes in monkey and human glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Posterior column ataxia with retinitis pigmentosa in a Japanese family with a novel mutation in FLVCR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Toll-like receptor 4 restricts retinal progenitor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

EGF and TGF-alpha stimulate retinal neuroepithelial cell proliferation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Oncomodulin links inflammation to optic nerve regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Is retinal photography useful in the measurement of stroke risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal microvascular changes and subsequent vascular events after ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Multiple sclerosis: can retinal imaging accurately detect optic neuritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Therapies for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Death and survival of neuronal cells exposed to Alzheimer's insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Alzheimer's disease: cerebral glaucoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Electrophysiologic responses in hamster superior colliculus evoked by regenerating retinal axons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Inactivation of Rho signaling pathway promotes CNS axon regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optic nerve involvement and diplopia as initial manifestations of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Retinal pathologic changes in multiple sclerosis

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

31 March 2020

12 December 2020

Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

31 March 2020

12 December 2020

Protective autoimmunity is a physiological response to CNS trauma.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Bone marrow mononuclear cells increase retinal ganglion cell survival and axon regeneration in the adult rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.227

Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas.

31 March 2020

1 reference

12 December 2020

Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration

1 reference

12 December 2020

Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo

1 reference

12 December 2020

An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography

1 reference

12 December 2020

The Case of Augustus d'Este (1794-1848): The First Account of Disseminated Sclerosis: (Section of the History of Medicine).

1 reference

12 December 2020

Expression of ceruloplasmin in the retina: induction after optic nerve crush.

1 reference

12 December 2020

Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells.

1 reference

12 December 2020

Ocular manifestations of autoimmune disease.

1 reference

12 December 2020

Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration

1 reference

12 December 2020

10.1038/NRNEUROL.2012.227

Identifiers

DOI

1 reference

PubMed ID

23165340

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23165340